Effect Of Coenzyme Q10 On Risk Of Atherosclerosis In Patients With Recent Myocardial Infarction
Notes for this study:
|| (umol/L)Mean and SD. COQ10: before 16.3 ± 2.7, after 32.4 ± 4.3. B vitamins: before 17.1 ± 2.8, after 22.1 ± 3.6.
|Number of Subjects
In a randomized, double-blind, controlled trial, 144 participants with recent myocardial infarctions took 120 mg of coq10 daily or a b-vitamin supplement daily for one year.
Funding issues for this study:
The group that received coenzyme q10 saw a statistically significantly greater increase in vitamins E and C, a greater reduction in TBARS, malondialdehyde, and diene conjugates with a greater increase in HDL but not total cholesterol or LDL.
There wasn't a statistically significant difference in sudden cardiac death, fatal myocardial infarction, or total cardiac deaths, and stroke, though the coq10 group experienced fewer of each. There was a statistically significant reduction in non-fatal myocardial infarction.
"Acknowledgements are due to Tishcon Corporation, Westbury, New York and Centre of Nutrition and Heart, Moradabad, India."